PAIN
Volume 127, Issue 1 , Pages 63-72 , January 2007

Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients

  • Donald D. Price

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University of Florida, Gainesville, FL 32610, USA
    • ,
  • Jason Craggs

      Affiliations

    • Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610, USA
    • ,
  • G. Nicholas Verne

      Affiliations

    • North Flordia/South Georgia Veteran Health System, University of Florida, Gainesville, FL 32610, USA
    • Department of Medicine, University of Florida, Gainesville, FL 32610, USA
    • ,
  • William M. Perlstein

      Affiliations

    • Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610, USA
    • Department of Psychiatry, University of Florida, Gainesville, FL 32610, USA
    • McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA
    • ,
  • Michael E. Robinson

      Affiliations

    • Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 352 273 6153; fax: +1 352 273 6156.

Received 8 March 2006 ,Revised 26 July 2006 ,Accepted 1 August 2006.

References 

  1. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;484–494
  2. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 1999;3639–3648
  3. Bushnell MC, Villemure C, Duncan GH. Psychophysical and neurophysiological studies of pain modulation by attention. In:  Price DD,  Bushnell MC editor. Psychological methods of pain control: basic science and clinical perspectives. Seattle, WA: I.A.S.P. Press; 2004;p. 99–116
  4. Fields HL, Price DD. Toward a neurobiology of placebo analgesia. In:  Harrington A editors. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press; 1997;p. 93–116
  5. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med. 1995;33:636–647
  6. Friston KJ, Frith CD, Frackowiak RS, Turner R. Characterizing dynamic brain responses with fMRI: a multivariate approach. Neuroimage. 1995;2:166–172
  7. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594–1602
  8. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med. 2004;256:91–100
  9. Hrobjartsson A, Gotzsche PC. Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies. J Clin Epidemiol. 2006;59:336–338
  10. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut. 1999;45(Suppl. 2):II17–II24
  11. Kong J, White NS, Kwong KK, Vangel MG, Rosman IS, Gracely RH, et al. Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum Brain Mapp. 2005;
  12. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci. 2006;26:381–388
  13. Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci. 2006;26:559–563
  14. Mayer DJ, Price DD. Central nervous system mechanisms of analgesia. Pain. 1976;2:379–404
  15. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40–52
  16. Montgomery GH, Kirsch I. Classical conditioning and the placebo effect. Pain. 1997;72:107–113
  17. Moulton EA, Keaser ML, Gullapalli RP, Greenspan JD. Regional intensive and temporal patterns of functional MRI activation distinguishing noxious and innocuous contact heat. J Neurophysiol. 2005;93:2183–2193
  18. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia – imaging a shared neuronal network. Science. 2002;295:1737–1740
  19. Price DD. Psychological mechanisms of pain and analgesia. vol. 15. Seattle, WA: IASP Press; 1999;
  20. Price DD, Barrell JJ. Mechanisms of analgesia produced by hypnosis and placebo suggestions. Prog Brain Res. 2000;122:255–271
  21. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999;83:147–156
  22. Schwartz JM, Stapp HP, Beauregard M. Quantum physics in neuroscience and psychology: a neurophysical model of mind-brain interaction. Philos Trans R Soc Lond B Biol Sci. 2005;360:1309–1327
  23. Talairach J, Tournoux P. Co-planar sterotaxic atlas of the human brain. New York: Thieme Medical Publishers; 1988;
  24. Taylor JG, Fragopanagos NF. The interaction of attention and emotion. Neural Netw. 2005;18:353–369
  25. Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain. 2002;99:443–452
  26. Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain. 2003;105:17–25
  27. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain. 2005;115:338–347
  28. Verne GN, Davis RH, Robinson ME, Gordon JM, Eaker EY, Sninksy CA. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol. 2003;98:1112–1116
  29. Verne GN, Himes NC, Robinson ME, Gopinath KS, Briggs RW, Crosson B, et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain. 2003;103:99–110
  30. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain. 2003;105:223–230
  31. Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked pain potentials. Brain Behav Immun. 2006;20:219–230
  32. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–1167
  33. Whitehead WE, Cheskin LJ, Heller BR, Robinson JC, Crowell MD, Benjamin C, et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology. 1990;98:1485–1489
  34. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25:7754–7762
  35. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311–315

PII: S0304-3959(06)00403-9

doi: 10.1016/j.pain.2006.08.001

PAIN
Volume 127, Issue 1 , Pages 63-72 , January 2007

Article Tools

* Image Usage & Resolution